Medtronic S7
This article was originally published in The Gray Sheet
Executive Summary
Seventh-generation AVE coronary stent system receives FDA approval, firm announces April 5. The S7 boasts shorter element lengths (1 mm) and a smaller cross-sectional area, providing additional flexibility to track through complex anatomy and reach difficult lesions that its S670 predecessor cannot. Device incorporates patented Discrete technology and offers perfusion capabilities at an average rate of 2 cc/minute at nominal pressure. Shipments began immediately to interventional cardiologists in the U.S. and abroad